Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty‐Related Limitation in Maintenance Hemodialysis Patients: A Cross‐Sectional Study
5 affiliations
- 1Department of Physical Therapy Allied Health Science at Fukuoka, International University of Health and Welfare Fukuoka Japan
- 2Wellness Center, Nagoya Kyoritsu Hospital Nagoya Japan
- 3Department of Molecular Medicine and Cardiology Nagoya University Graduate School of Medicine Nagoya Japan
- 4Department of Cardiology Nagoya University Graduate School of Medicine Nagoya Japan
- 5Department of Cardiology Nagoya Kyoritsu Hospital Nagoya Japan
Abstract
Background: Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and objective measures of physical function in MHD patients, excluding previously planned cardiac data.
Methods: This cross‐sectional study included 23 MHD outpatients. We assessed physical function using the Short Physical Performance Battery (SPPB) score and the 5‐Sit‐to‐Stand Test (5‐SST). We also measured body composition, physical activity (accelerometer‐derived step count), and serum concentrations of myonectin, adiponectin, and omentin. Correlation analysis and comparison between high (≧ median) and low (< median) myonectin groups were performed.
Results: Serum myonectin was positively correlated with Body Mass Index (BMI) and the SPPB score. No significant correlations were observed between myonectin and other physical function or physical activity indicators. Furthermore, the high myonectin group showed significantly better performance compared to the low group, completing the 5‐SST in a shorter time and achieving a higher SPPB score. Adiponectin showed significant inverse correlations with BMI, muscle mass, and fat mass.
Conclusion: Serum myonectin levels are positively associated with superior physical function (SPPB) and faster lower‐extremity performance (5‐SST) in MHD patients. Myonectin may serve as a simple, novel biomarker to identify MHD patients with better preserved functional capacity and potentially less frailty‐related limitation. These findings underscore the critical role of muscle health in maintaining function in this vulnerable population.
Related
- Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
- A greater number of selected clinical abnormalities is associated with higher erythropoiesis resistance index in maintenance hemodialysis: a repeated patient-month analysis
- Prevalence and factors associated with physical function among patients undergoing maintenance hemodialysis in Buraydah, Saudi Arabia: a cross-sectional study.
- Development of a nomogram for identifying prevalent medication discrepancy in maintenance hemodialysis patients: a multicenter cross-sectional study
- Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data
BibTeX
@article{kono2026serum,
title = {{Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty‐Related Limitation in Maintenance Hemodialysis Patients: A Cross‐Sectional Study}},
author = {Kenichi Kono and Yoshifumi Moriyama and Koji Ohashi and Naoya Otaka and Minako Tatsumi and Toyoaki Murohara and Noriyuki Ouchi and Satoru Oshima},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
month = jun,
doi = {10.1002/1744-9987.70177},
url = {https://doi.org/10.1002/1744-9987.70177},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Serum Myonectin Levels Are Positively Associated With Physical Function and Lower Frailty‐Related Limitation in Maintenance Hemodialysis Patients: A Cross‐Sectional Study
AU - Kenichi Kono
AU - Yoshifumi Moriyama
AU - Koji Ohashi
AU - Naoya Otaka
AU - Minako Tatsumi
AU - Toyoaki Murohara
AU - Noriyuki Ouchi
AU - Satoru Oshima
PY - 2026
DA - 2026/06/28
JO - Therapeutic Apheresis and Dialysis
DO - 10.1002/1744-9987.70177
UR - https://doi.org/10.1002/1744-9987.70177
AB - Background: Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and objective measures of physical function in MHD patients, excluding previously planned cardiac data. Methods: This cross‐sectional study included 23 MHD outpatients. We assessed physical function using the Short Physical Performance Battery (SPPB) score and the 5‐Sit‐to‐Stand Test (5‐SST). We also measured body composition, physical activity (accelerometer‐derived step count), and serum concentrations of myonectin, adiponectin, and omentin. Correlation analysis and comparison between high (≧ median) and low (< median) myonectin groups were performed. Results: Serum myonectin was positively correlated with Body Mass Index (BMI) and the SPPB score. No significant correlations were observed between myonectin and other physical function or physical activity indicators. Furthermore, the high myonectin group showed significantly better performance compared to the low group, completing the 5‐SST in a shorter time and achieving a higher SPPB score. Adiponectin showed significant inverse correlations with BMI, muscle mass, and fat mass. Conclusion: Serum myonectin levels are positively associated with superior physical function (SPPB) and faster lower‐extremity performance (5‐SST) in MHD patients. Myonectin may serve as a simple, novel biomarker to identify MHD patients with better preserved functional capacity and potentially less frailty‐related limitation. These findings underscore the critical role of muscle health in maintaining function in this vulnerable population.
SN - 1744-9979
SN - 1744-9987
ER -